Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
1,180,000
+180,000
+18% +$357K 1.9% 9
2026
Q1
$1.57M Hold
1,000,000
1.01% 11
2025
Q4
$1.85M Buy
1,000,000
+168,900
+20% +$294K 1.34% 11
2025
Q3
$1.33M Hold
831,100
0.97% 12
2025
Q2
$1.45M Buy
831,100
+251,100
+43% +$420K 1.03% 12
2025
Q1
$1.39M Buy
580,000
+30,000
+5% +$98.2K 1% 13
2024
Q4
$1.95M Hold
550,000
1.4% 12
2024
Q3
$2.33M Buy
550,000
+15,000
+3% +$64.9K 1.5% 11
2024
Q2
$2.01M Buy
535,000
+285,000
+114% +$1.3M 1.31% 12
2024
Q1
$1.35M Buy
250,000
+75,000
+43% +$432K 0.9% 12
2023
Q4
$1.08M Buy
175,000
+65,000
+59% +$320K 0.66% 15
2023
Q3
$571K Buy
110,000
+25,000
+29% +$133K 0.38% 17
2023
Q2
$428K Buy
+85,000
New +$345K 0.28% 20

Other funds holding OABI

TowerView LLC's OABI Position: Q2 2026 in Review

TowerView LLC increased its OmniAb (OABI) stake by 18% in Q2 2026, buying an estimated $357K and bringing the position to 1,180,000 shares worth $2.9M. The position accounts for 1.9% of the portfolio, ranked #9.

TowerView LLC first reported a position in OABI in Q2 2023 and has held it in 13 quarters since. 131 funds tracked by Wall St. Rank hold OABI as of Q2 2026.

  • TowerView LLC held 1,180,000 shares of OmniAb worth $2.9M as of Q2 2026.
  • TowerView LLC bought 180,000 OmniAb shares in Q2 2026, an estimated $357K.
  • OmniAb made up 1.9% of TowerView LLC's portfolio in Q2 2026, its #9 holding.
  • TowerView LLC first reported a position in OmniAb in Q2 2023 and has held it in 13 quarters since.
  • 131 funds tracked by Wall St. Rank held OmniAb as of Q2 2026.

Based on TowerView LLC's 13F filing for Q2 2026, filed 4 Aug 2026.